Breathing Retraining Beneficial in Patients With Asthma

This article originally appeared here.
Share this content:
Breathing Retraining Beneficial in Patients With Asthma
Breathing Retraining Beneficial in Patients With Asthma

THURSDAY, Dec. 14, 2017 (HealthDay News) -- A breathing retraining intervention, delivered digitally or via face-to-face sessions can improve quality of life in patients with asthma, according to a study published online Dec. 13 in The Lancet Respiratory Medicine.

Anne Bruton, Ph.D., from the University of Southampton in the United Kingdom, and colleagues recruited patients from 34 general practices into a randomized trial. A self-guided intervention was developed, which was delivered as a DVD and a printed booklet (DVDB). A total of 655 patients with general practitioner-diagnosed asthma were randomized to receive either the DVDB intervention, three face-to-face breathing retraining sessions, or standard care for 12 months.

The researchers found that the Asthma Quality of Life Questionnaire (AQLQ) scores were significantly higher in the DVDB and face-to-face versus usual care groups (mean, 5.40 and 5.33 versus 5.12; adjusted mean difference, 0.28 and 0.24, respectively). Similar AQLQ scores were seen between the DVDB and face-to-face groups (adjusted mean difference, 0.04). The randomization groups did not differ in terms of forced expiratory volume in one second or fraction of exhaled nitric oxide.

"Breathing retraining programs improve quality of life in patients with incompletely controlled asthma despite having little effect on lung function or airway inflammation," the authors write. "Such programs can be delivered conveniently and cost-effectively as a self-guided digital audiovisual program, so might also reduce health care costs."

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »